Scancell Holdings (GB:SCLP) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Scancell Holdings plc, a developer of novel immunotherapies for cancer treatment, is set to announce its annual financial results on September 24, 2024. A live webcast and conference call featuring a Q&A session will be hosted by CEO Professor Lindy Durrant and CFO Sath Nirmalananthan. Scancell leverages proprietary technology platforms to create innovative cancer therapeutics and has a pipeline of products targeting unmet needs in oncology.
For further insights into GB:SCLP stock, check out TipRanks’ Stock Analysis page.
